QualityStocksNewsBreaks Archives - Page 357 of 1457

FridayJan 13, 2023 3:45 pm

QualityStocksNewsBreaks – REZYFi Inc. Positioning to Operate Competitively in Challenging Lending Markets

REZYFi, a specialized financing company and a growing mortgage lender, is working to help businesses navigate the challenging landscape of loan origination, particularly as it applies to the traditionally underserved cannabis industry and property owners who lease to such companies. “REZYFi is anticipating the launch of its high-margin cannabis division in the coming weeks to focus on such challenging lending markets. The company is developing a proprietary technology that will help it operate competitively by maintaining efficient turnaround time while also being economical with staffing levels,” a recent article reads. “Through its subsidiaries, REZYFi Lending and ResMac Inc., the company…

FridayJan 13, 2023 3:19 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Enabling SMBs to Build Highly Effective Cybersecurity and Privacy Programs

SideChannel (OTCQB: SDCH) is guided by the belief that small and mid-sized businesses (“SMBs”) deserve the expertise of an experienced chief information security officer (“CISO”) just as much as a larger enterprise but at a more reasonable cost. “The company is helping organizations all over the world improve their cybersecurity and move their mission forward. SideChannel matches companies with an expert virtual CISO (‘vCISO’), so companies can assess cyber risk and ensure cybersecurity compliance – all without jeopardizing financial assets,” a recent article explains. “SideChannel sees its role as to make it as easy as possible for small and mid-sized…

FridayJan 13, 2023 12:57 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical Needs

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently announced statistically significant (p<0.001) efficacy results in a preclinical in-vivo proof-of-concept study of its innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy. “The study concluded that compared to pre-infection weight, the control group’s weight declined on average at 12.01%. In contrast, on average, the weight of the experimental group using BiondVax’s NanoAb therapy declined only 3.80%. The successful result of the study was further supported by eight other tracked parameters, including heart rate and social behaviors,…

FridayJan 13, 2023 12:46 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Opportunity Following Recent Exploratory Work at Its Iska Iska Project

Eloro Resources’ (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) EVP of Exploration Bill Pearson was recently part of an interview on Business TV (“BTV”) where he expressed his optimism on the company’s prospects following its recent exploratory work at its Iska Iska project located in southern Bolivia. “[Pearson also simultaneously suggested] that the possibility that Eloro could potentially uncover a world-class, multimillion-ounce deposit of silver and tin within the Iska Iska project may not be far off from the realm of possibility. Over the past two years, Eloro Resources has drilled upwards of 102 holes and over 70,000 cumulative meters across…

FridayJan 13, 2023 12:36 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc. Reinventing Home Energy Market

GeoSolar Technologies (“GST”) offers its SmartGreen(TM) solution, which can be retrofitted to existing homes or built into new developments in any climate with an installation process that takes just a few weeks. “The comprehensive program includes sealing and insulating the ‘shell’ or ‘envelope’ of the house (exterior walls, attic, etc.), eliminating any usage of fossil fuels (natural gas, heating oil, propane) in favor of high-efficiency electric appliances and mechanicals, and installation of rooftop solar panels as the new energy source, geothermal ground loops used in heating and cooling, electric heat pump and water heater, floor loops, LED lighting, air purification…

FridayJan 13, 2023 10:30 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) CEO Reports on Company Accomplishments, Outlook through Shareholder Letter

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, is in an ideal position to be “profitable” in 2023. That was the outlook reported in a shareholder letter released by JUPW CEO Brian John. The letter noted 2022 highlights, such as the company becoming the second U.S. equity to dual list on Upstream, a revolutionary trading app for digital securities and NFTs, and JUPW’s SRM Entertainment division submitting a confidential registration statement to the SEC on a key step on its journey to becoming an independently traded NASDAQ company. The letter also noted that Jupiter Wellness…

FridayJan 13, 2023 9:30 am

QualityStocksNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) CEO Featured on Gamechangers LIVE(R)

Cerberus Sentinel (NASDAQ: CISO) founder and CEO David Jemmett was featured on a recent episode of Gamechangers LIVE(R) with host Sergio Tigera. The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspectives on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. In the episode, Jemmett discusses his extensive background in the field and the origins of Cerberus Sentinel, an industry leader in cybersecurity and compliance services that leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. “If…

ThursdayJan 12, 2023 2:28 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Moves Closer Toward Broad Applications of Patented DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX) in 2022 achieved crucial milestones centered around its patented DehydraTECH(TM) drug delivery technology. “For Lexaria, the end goal does not only lie in uncovering DehydraTECH’s ability to improve the bioavailability of various APIs. Instead, the company is keen on establishing whether DehydraTECH can be applied broadly within the pharmaceutical industry. And calendar 2022 has brought Lexaria closer to realizing this goal, with the company initiating a slew of research programs, many of which it has already completed. Moreover, its intellectual property (‘IP’) portfolio received additional patent protection in different jurisdictions around the world. Lexaria also…

ThursdayJan 12, 2023 2:18 pm

QualityStocksNewsBreaks – Coyuchi Inc. Positioned to Propel Its New Growth Phase

Coyuchi is setting the gold standard in sustainable luxury home goods, offering organic bedding, sheets, towels, apparel, and more for the environmentally conscious home. “For 30 years, Coyuchi has explored organic farming and sustainable textiles, and guarantees the highest environmental and ethical standards through its acquisition of certifications, including the Global Organic Textile Standard (‘GOTS’), Fair Trade Certified, and MADE SAFE(R). Backed by a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base driving the fast-growing organic luxury market, Coyuchi is positioned to propel its new growth phase as the world awakens to sustainability at scale,”…

ThursdayJan 12, 2023 1:10 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin to Be Evaluated in Investigator-Initiated Phase 1b/2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced an investigator-initiated phase 1b /2 trial evaluating the company’s novel anthracycline, Berubicin. The study, titled “Evaluation of the safety and efficacy of Berubicin in the treatment of central nervous system lymphomas,” will be conducted at the Pomeranian Medical University (“PUM”) in Szczecin, Poland. “Based on the data seen to date, Berubicin has continued to demonstrate an overall safety profile more favorable than other known anthracyclines and we remain encouraged by its potential.…

Site Search

Company Search

Category: QualityStocksNewsBreaks